Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s flagship product line—VI Peel—comprises six medical-grade chemical peel formulations designed to address a range of dermatological concerns including hyperpigmentation, melasma, sun damage, acne/acne scarring, fine lines/wrinkles and body-related skin issues. These peels are widely used by clinicians globally and have demonstrated rapid visible results with high safety across all skin types. The company also offers the VI Derm clinical skincare line to complement in-office procedures. No clinical trial data typical of pharmaceutical development; efficacy supported by practitioner adoption and before-after evidence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitality Institute.